Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Gastroenterology Physician in Long Beach, CA
NPI: 1174630586Primary Practice Location
VA LONG BEACH HEALTHCARE SYSTEM
5901 E 7th St, Long Beach, CA
Primary Employer
VA Long Beach Healthcare System
va.gov
HQ Phone
Get M.D. Timothy's Phone Numberphone_androidMobile
Get M.D. Timothy's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1979 - 2027
AZ State Medical License
1985 - 1987
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Gastroenterology
LAC-USC Medical Center
Fellowship • Hepatology
1982 - 1983
Fellowship • Hepatology
1985 - 1986
University of Arizona College of Medicine-Tucson
Fellowship • Gastroenterology
1983 - 1985
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Internal Medicine
1978 - 1982
Emory School of Medicine
med.emory.edu
Medical School
Until 1978
Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection
Authors: Ke-Qin Hu
Publication Date: 2005-08
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Authors: William Lee
Journal: N Engl J Med
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
Authors: Herbert Bonkovsky, Howard Strickler, Brian Edlin
Publication Date: 2014-12-02
Lead Sponsor: Timothy Morgan, MD
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Intervention / Treatment: DRUG: Standard of care, DRUG: Standard of care + pegfiltrastim
Lead Sponsor: University of Florida
Collaborators: AbbVie, Merck Sharp & Dohme LLC, Patient-Centered Outcomes Research Institute
Intervention / Treatment: DRUG: Ribavirin, DRUG: SOF/LDV (sofosbuvir/ledipasvir), DRUG: PrOD (ombitasvir/paritaprevir/ritonavir with dasabuvir) (Phase 1 only), DRUG: EBR/GZR (elbasvir/grazoprevir)
Lead Sponsor: Southern California Institute for Research and Education
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA), University of Southern California, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, VA Long Beach Healthcare System
Intervention / Treatment: DRUG: Rilonacept, DRUG: Mycophenolate mofetil, DRUG: Prednisolone
